Studies on the antimicrobial activity and brine shrimp toxicity of Zeyheria tuberculosa (Vell.) Bur. (Bignoniaceae) extracts and their main constituents

Background Due to the indiscriminate use of antimicrobial drugs, the emergence of human pathogenic microorganisms resistant to major classes of antibiotics has been increased and has caused many clinical problems in the treatment of infectious diseases. Thus, the aim of this study was to evaluate for the first time the in vitro antimicrobial activity and brine shrimp lethality of extracts and isolated compounds from Zeyheria tuberculosa (Vell.) Bur., a species used in Brazilian folk medicine for treatment of cancer and skin diseases. Methods Using the disc diffusion method, bioautography assay and brine shrimp toxicity test (Artemia salina Leach), we studied the antimicrobial activity and lethality of extracts and isolated compounds against three microorganisms strains, including Gram-positive (Staphylococcus aureus) and Gram-negative (Pseudomonas aeruginosa) bacteria and yeasts (Candida albicans). Results In this study, the extracts inhibited S. aureus (8.0 ± 0.0 to 14.0 ± 0.0 mm) and C. albicans (15.3 ± 0.68 to 25.6 ± 0.4 mm) growth. In the brine shrimp test, only two of them showed toxic effects (LC50 29.55 to 398.05 μg/mL) and some extracts were non-toxic or showed weak lethality (LC50 705.02 to > 1000 μg/mL). From these extracts, four flavones [5,6,7,8-tetramethoxyflavone (1), 5,6,7-trimethoxyflavone (2), 4'-hydroxy-5,6,7,8-tetramethoxyflavone (3), and 4'-hydroxy-5,6,7-trimethoxyflavone (4)] were isolated through bioassay-guided fractionation and identified based on the 1D and 2D NMR spectral data. By bioautography assays, compounds 1 [S. aureus (16.0 ± 0.0 mm) and C. albicans (20.0 ± 0.0 mm)] and 3 [S. aureus (10.3 ± 0.6 mm) and C. albicans (19.7 ± 0.6 mm)] inhibited both microorganisms while 2 inhibited only S. aureus (11.7 ± 0.6 mm). Compound 4 did not restrain the growth of any tested microorganism. Conclusion Our results showed that extracts and isolated flavones from Z. tuberculosa may be particularly useful against two pathogenic microorganisms, S. aureus and C. albicans. These results may justify the popular use this species since some fractions tested had antimicrobial activity and others showed significant toxic effects on brine shrimps. However, in order to evaluate possible clinical application in therapy of infectious diseases, further studies about the safety and toxicity of isolated compounds are needed.


Background
The research into biologically active compounds from natural sources has always been of great interest for scientists looking for new sources of useful drugs against infectious diseases [1]. It is known that the antibiotics commonly used are sometimes associated with adverse effects on the host [2][3][4]. In recent years, resistance to these drugs by pathogenic bacteria microorganisms has increased and this had caused serious clinical problems in the treatment of infectious diseases [5,6].
The effects of antibiotic resistance have been reflected in the agriculture, food, medical, and pharmaceutical industries. Though pharmacological industries have produced a number of new antibiotics, in the last three decades, yet resistance to these drugs by microorganisms has developed. According to the WHO, medicinal plants would be the best source for obtaining a variety of drugs and a possible way to treat diseases caused by multidrug resistant bacteria [7]. Thus, the in vitro antimicrobial activity could provide the needed preliminary observations necessary to select medicinal plants with potentially useful properties for to develop novel antibiotic prototypes [8].
The aim of this investigation was to evaluate for the first time the in vitro antimicrobial activity and brine shrimp lethality of extracts and isolated compounds from Z. tuberculosa, popularly known as "ipê-preto", against three strains of microorganisms (S. aureus, P. aeruginosa and C. albicans). This plant was selected because in Brazil it has been used for treatment of cancer and skin diseases [11] and there is no antimicrobial study on this species.

Preparation of the extracts and isolation of the constituents
The air-dried and powdered stems (900 g) were extracted at room temperature with ethanol (EtOH) 90%. The solution was filtered using Whatman N° 1 filter paper under suction and concentrated to dryness at 50°C under reduced pressure. The obtained EtOH extract (7.72 g) was partitioned between hexane, chloroform (CHCl 3 ) and hydro-alcoholic (MeOH-H 2 O, 7:3) solution. After that, the methanol (MeOH) was removed under vacuum and the aqueous portion was further extracted with ethyl acetate (EtOAc). Hexane extract (2.9 g) was separated into neutral (1.4 g) and acid (1.5 g) constituents with NaOH 2%. All extracts from these procedures [EtOH, hexane acid (1.4 g), hexane neutral (1.42 g), CHCl 3 (2.6 g), EtOAc (0.6 g), and MeOH H 2 O (1.5 g)] were evaluated as antimicrobial by disc diffusion method and for lethality to brine shrimp larvae (Artemia salina Leach).

Antimicrobial assays
In this study, strains of S. aureus (ATCC 25923), P. aeruginosa (ATCC 27853) and C. albicans (ATCC 10231) were used to investigate the antimicrobial potential of the extracts and isolated constituents by disc diffusion method [14]. Stock solutions of the samples [crude extract (50 mg/ mL) and fractions (25 mg/mL)] were prepared in chloroform or methanol (HPLC degree, Merck). Further, these solutions were then diluted to give final concentrations ranging from 6.25 to 1000 μg/disc and kept at 4°C prior to use. Sterile discs (6 mm diameter) of vancomycin (30 μg), ciprofloxacin (5 μg), and miconazole (50 μg) were used as positive controls. In order to avoid any effect of the solvent, methanol and chloroform were used as negative controls. The microorganism cultures were grown in Brain Infusion Heart (BIH) liquid medium at 35°C (for bacteria) and 28°C (for yeast), and the microorganisms were kept under refrigeration (4°C) until use. After 24 h (for bacteria) and 48 h (for yeast) of growth, each microorganism, at a concentration of 1.5 × 10 6 cells/mL (adjusted to the 0.5 McFarland turbidity standards) [15,16], was inoculated on the surface of Mueller Hinton agar (for bacteria) and Saboraud dextrose agar (for yeast) plates. Sterile filter paper discs (6 mm in diameter) saturated either with extract or fractions were impregnated, in triplicate, with 20 μL of the stock solutions (1000 and 500 μg/disc for extract and fractions, respectively) on surface of each inoculated plate. After holding the plates at room temperature for 1 h to allow diffusion of test samples into the agar, they were incubated [17]. After that, the results were recorded by measuring the zones of growth inhibition around the discs, and presented as the arithmetic average (mean value ± standard deviation). Overall, cultured microorganisms with halos equal to or greater than 7 mm were considered susceptible to samples tested. The data were analyzed using the statistical method of PROBIT analysis with the aid of the SPSS 11.5 computation package (SPSS Inc., Chicago, Illinois, USA).

Bioautography assay
Isolated compounds (1)(2)(3)(4) were evaluated by bioautography technique [18]. An aliquot each sample dissolved in chloroform or methanol or mixture of both [bacteria (10 μg) and yeast (50 μg)] was applied over a chromatosheet of silica gel 60 F 254 followed by elution with a system of hexane-EtOAc (7:3) and air-drying. Further, a layer of Mueller Hinton agar medium (for bacteria) or Saboraud dextrose agar (for yeast) containing 1.5 × 10 6 cells/mL of each microorganism suspension separately was inoculated and sprayed with fresh culture over a developed TLC plate and incubated for 24 h at 35°C (for bacteria) and 48 h at 28°C (for yeast). Each treatment was replicated three-times and gentamicin (10 μg), miconazole (50 μg), solvents and samples-free solutions were used as drugs controls and blank. The inhibition of growth by the compounds on the plates was visualized as white spots against the deep red background after spraying the plates with 2,3,5-triphenyltetrazolium chloride aqueous solution (2.0 mg/mL). The results were recorded by measuring the zones of growth inhibition around the spots and presented as the arithmetic average (mean value ± standard deviation).

Brine shrimp toxicity assay
The most promising as antimicrobial fractions (hexane acid, hexane-CHCl 3 1:1, CHCl 3 , and CHCl 3 -MeOH 1:1) were evaluated for lethality to brine shrimp larvae (A. salina Leach) according to the procedures described by Meyer et al. [19] and Solis et al. [20]. Brine shrimp eggs were hatched for 48 h in a conical flask containing 300 mL of seawater. The flasks were well aerated with the aid of an air pump and kept in a water bath at 29-30°C. A bright light source was left on and the nauplii hatched within 48 h. The fractions were dissolved in 1% aqueous DMSO to obtain a concentration of 1 mg/mL. These were serially diluted three-times and different concentrations were obtained (1000 to 12.5 μg/mL). An aliquot of each concentration (1 mL) was transferred, in triplicate, into clean sterile universal vials with pipette, and aerated seawater (9 mL) was added. Ten shrimp nauplii were transferred to each vial (30 shrimps per concentration). Thymol 1% aqueous solution [21] and 1% DMSO in seawater were used as positive and negative controls, respectively. After 24 h the numbers of survivors were counted and percentage of death calculated. The concentration that killed 50% of the nauplii (LC 50 in μg/mL and Confidence Intervals 95%) was determined using the statistical method of PROBIT analysis with the aid of the SPSS 11.5 computation package (SPSS Inc., Chicago, IL, USA) [22]. Criterion of toxicity for fractions was established according to Déciga-campos et al. [23]: LC 50 values > 1000 μg/mL (non-toxic), ≥ 500 ≤ 1000 μg/mL (weak toxicity) and < 500 μg/mL (toxic).

Antimicrobial activity
In this study, no negative controls exhibited antimicrobial activity and compared with positive controls [vancomycin (15.0 ± 0.51 mm) and miconazole (26.0 ± 0.68 mm)], the extracts had significant inhibition against S. aureus and C. albicans. In general, medium inhibition zones ranged from 9.0 ± 0.0 to 13.7 ± 0.71 mm and 10.7 ± 0.0 to 25.6 ± 0.4 mm for S. aureus and C. albicans, respectively. Among extracts tested, three of the fractions from chromatographic fractionation effectively inhibited the growth of both microorganisms [hexane-CHCl

Discussion
Plants are known to produce some chemical constituents, which are naturally toxic to bacteria and fungi [29]. Traditionally they are used to treat systemic bacterial and yeast infections, as well applied directly on the skin or nails in a plaster form to treat local infections [30]. Despite the significant progress made in molecular biology and synthetic chemistry that can lead to the development of new drugs, plants have been a potential source of bioactive compounds. In this study, extracts from stems of Z. tuberculosa showed to be effective against S. aureus and C. albicans, pathogenic microorganisms known to constitute a significant cause of nosocomial infection and morbidity mainly among immune compromised and severely ill patients [31,32].
Although there are some reports showing that polar extracts inhibited the growth of both Grampositive and Gram-negative bacteria [33,34], in the present study, crude ethanol extract [S. aureus (9.0 ± 0.16 mm) and C. albicans (17.3 ± 0.4 mm)] inhibited only the growth of S. aureus (Gram-positive) and C. albicans (yeast). This extract was partitioned and only two of remaining extracts (hexane and chloroform) showed significant against S. aureus and/or C. albicans, and no activity was observed for the most polar extracts (ethyl acetate and hydroalcoholic).
Several studies have shown that brine shrimp assay has been an excellent method for preliminary investigations of toxicity, to screen medicinal plants popularly used for several purposes and for monitoring the isolation a great variety of biologically active compounds [35]. The technique is easily mastered, costs little, and utilizes small amount of test material. Since its introduction [19], this in vivo test has been successively employed for bioassayguide fractionation of active cytotoxic and antitumor agents [36]. Furthermore, a positive correlation between the lethality to brine shrimp and the corresponding oral lethal dose in mice of medicinal plants has been demonstrated by Parra et al. [37]. The results obtained in this study may be support the popular use of Z. tuberculosa in Brazil for the treatment of cancer since some fractions showed significant toxic effects on brine shrimps.
From the chloroform and CHCl 3 -MeOH 1:1 fractions, four flavones (1-4) were isolated and also evaluated through bioautography assay against the same microorganisms previously mentioned. Our results showed that the response in terms of susceptibility the response to the microorganism tested varied among them. Compounds 1 and 3, which have four methoxyl groups in the ring A, were actives for S. aureus and C. albicans while compound 2 (5,6,7-trimethoxyflavone), which lacks a methoxyl group at C-8 of this ring, was active only for C. albicans.
On the other hand, compound 4 (4'-hydroxy-5,6,7-trimethoxyflavone), which lacks a methoxyl group at C-8 and has a hydroxyl group at C-4', in comparison with the similar compound 3, did not affect the growth of the tested microorganisms. These results suggested that the presence of methoxyl group at C-8 can be responsible for the antibacterial activity and that minor structural differences among these flavones influence their antimicrobial activity, bringing new perspectives to studies on the structure-activity relationship of this type of metabolites.

Conclusion
In Brazil, the species Z. tuberculosa has been used in traditional medicine for treatment of cancer and skin diseases. Then, the results obtained in this study may justify the popular use this species since some fractions tested had antimicrobial activity and others showed significant toxic effects on brine shrimps. In addition, our results demonstrated that flavones isolated from this species present in vitro antimicrobial activity. However, in order to evaluate possible clinical application in therapy of infectious diseases, further studies about the safety and toxicity of the isolated compounds are needed.

'
Publish with Bio Med Central and every scientist can read your work free of charge